• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素与阿片受体系统在介导乙醇效应中的相互作用。

Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects.

作者信息

Manzanares Jorge, Ortiz Sergio, Oliva José M, Pérez-Rial Sandra, Palomo Tomás

机构信息

Edificio Materno-Infantil, Planta 6, 613-A, Hospital Universitario 12 de Octubre, Avda. Cordoba s/n, 28041 Madrid, Spain.

出版信息

Alcohol Alcohol. 2005 Jan-Feb;40(1):25-34. doi: 10.1093/alcalc/agh112. Epub 2004 Nov 18.

DOI:10.1093/alcalc/agh112
PMID:15550451
Abstract

Over the past few years, advances in the investigation of the neurochemical circuits involved in the development and treatment of alcohol dependence have identified peptides and receptors as potential key targets in the treatment of problems related to alcohol consumption. The endogenous opioid system is modified by alcohol intake in areas of the brain related to reward systems, and differential basal levels of opioid gene expression are found in rodents with a high preference for ethanol. This suggests a greater vulnerability to alcohol consumption in relation to differences in genetic background. Further evidence of the involvement of opioid peptides in alcohol dependence is the ability of the opioid antagonist naltrexone to reduce alcohol intake in animal models of dependence and in alcohol-dependent patients. Abundant evidence indicates that the activation of cannabinoid receptors stimulates the release of opioid peptides, therefore the cannabinoid receptor antagonists may presumably alter opioid peptide release, thus facilitating the reduction of ethanol consumption. However, little is known about the effects of ethanol on the endogenous cannabinoid system, the vulnerability of cannabinoid receptors to alcohol intake or their neurochemical implications in reducing consumption of alcohol. In this paper, we review the role of opioid and cannabinoid receptor systems, their vulnerability to alcohol intake and the development of dependence, and the targeting of these systems in the treatment of alcoholism.

摘要

在过去几年中,对参与酒精依赖发展与治疗的神经化学回路的研究进展已将肽类和受体确定为治疗与饮酒相关问题的潜在关键靶点。内源性阿片系统在大脑中与奖赏系统相关的区域会因酒精摄入而发生改变,并且在对乙醇有高度偏好的啮齿动物中发现了阿片类基因表达的基础水平差异。这表明,相对于遗传背景的差异,个体对酒精消费的易感性更高。阿片肽参与酒精依赖的进一步证据是,阿片拮抗剂纳曲酮能够在依赖动物模型和酒精依赖患者中减少酒精摄入量。大量证据表明,大麻素受体的激活会刺激阿片肽的释放,因此大麻素受体拮抗剂可能会改变阿片肽的释放,从而有助于减少乙醇消费。然而,关于乙醇对内源性大麻素系统的影响、大麻素受体对酒精摄入的易感性或它们在减少酒精消费方面的神经化学意义,我们所知甚少。在本文中,我们综述了阿片和大麻素受体系统的作用、它们对酒精摄入和依赖发展的易感性,以及这些系统在酒精中毒治疗中的靶向作用。

相似文献

1
Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects.大麻素与阿片受体系统在介导乙醇效应中的相互作用。
Alcohol Alcohol. 2005 Jan-Feb;40(1):25-34. doi: 10.1093/alcalc/agh112. Epub 2004 Nov 18.
2
Endogenous opioid systems and alcohol addiction.内源性阿片系统与酒精成瘾。
Psychopharmacology (Berl). 1997 Jan;129(2):99-111. doi: 10.1007/s002130050169.
3
Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats.口服洛哌丁胺对纳曲酮、巴氯芬和 AM-251 阻断大鼠乙醇自我给药疗效的影响。
Pharmacol Biochem Behav. 2012 Jan;100(3):530-7. doi: 10.1016/j.pbb.2011.10.019. Epub 2011 Oct 25.
4
[Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].μ-阿片受体拮抗剂纳曲酮对酒精依赖的药理作用
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Oct;43(5):697-704.
5
Role of the endocannabinoid system in the development of tolerance to alcohol.内源性大麻素系统在酒精耐受性形成中的作用。
Alcohol Alcohol. 2005 Jan-Feb;40(1):15-24. doi: 10.1093/alcalc/agh111. Epub 2004 Nov 18.
6
Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice.纳曲酮对C57BL/6J小鼠乙醇摄入习得及已确立的乙醇消耗量的影响。
Alcohol Clin Exp Res. 1997 Jun;21(4):691-702.
7
Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.持续给予纳曲酮和纳美芬会导致在减少酒精摄入方面产生耐受性,并导致脑阿片受体超敏。
Addict Biol. 2017 Jul;22(4):1022-1035. doi: 10.1111/adb.12393. Epub 2016 Mar 15.
8
Recent developments in alcoholism:opioid peptides.酒精中毒的最新进展:阿片肽
Recent Dev Alcohol. 1993;11:187-205.
9
[Opioid antagonists and alcohol consumption].[阿片类拮抗剂与酒精消费]
Rev Neurol. 2007;45(3):155-62.
10
Opioid involvement in alcohol drinking.阿片类物质与饮酒的关联。
Ann N Y Acad Sci. 1994 Oct 31;739:156-67. doi: 10.1111/j.1749-6632.1994.tb19817.x.

引用本文的文献

1
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.探索首个利莫那班类似物-阿片肽杂合化合物,作为CB1和阿片受体的双价配体。
J Enzyme Inhib Med Chem. 2017 Dec;32(1):444-451. doi: 10.1080/14756366.2016.1260565.
2
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons.乙醇与基底外侧杏仁核主神经元上γ-氨基丁酸能突触处的内源性大麻素系统之间的相互作用。
Alcohol. 2015 Dec;49(8):781-94. doi: 10.1016/j.alcohol.2015.08.006. Epub 2015 Oct 27.
3
Voluntary alcohol drinking enhances proopiomelanocortin gene expression in nucleus accumbens shell and hypothalamus of Sardinian alcohol-preferring rats.
自愿饮酒增强了撒丁岛酒精偏好大鼠伏隔核壳和下丘脑的前阿黑皮素原基因表达。
Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1(0 1):E131-40. doi: 10.1111/j.1530-0277.2012.01867.x. Epub 2012 Jun 22.
4
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.内源性大麻素对药物强化、依赖和成瘾相关行为的影响。
Pharmacol Ther. 2011 Dec;132(3):215-41. doi: 10.1016/j.pharmthera.2011.06.005. Epub 2011 Jul 18.
5
How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.大脑对酒精的适应如何导致成瘾:药理学视角
Alcohol Res Health. 2008;31(4):310-39.
6
Ethanol drinking in rodents: is free-choice drinking related to the reinforcing effects of ethanol?啮齿动物中的乙醇摄入:自由选择饮酒与乙醇的强化作用有关吗?
Alcohol. 2008 Feb;42(1):1-11. doi: 10.1016/j.alcohol.2007.10.005.
7
The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence.大麻素CB1受体拮抗剂利莫那班作为一种有前景的酒精依赖药物疗法:临床前证据
Mol Neurobiol. 2007 Aug;36(1):102-12. doi: 10.1007/s12035-007-0017-y. Epub 2007 Jul 3.
8
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.酒精中毒的神经药理学治疗进展:科学依据与临床发现
Biochem Pharmacol. 2008 Jan 1;75(1):34-56. doi: 10.1016/j.bcp.2007.08.005. Epub 2007 Aug 9.